The South London Stroke Register is a long-running population-based stroke register including
all patients with first stroke occuring in a defined area of London. The study area comprises
27 electoral wards in the Northern part of Lambeth and Southwark and participant's residence
within these wards is confirmed by postcode.
Information on the population denominator, including sociodemographic details of the
catchment area, is obtained through the ONS.
Notification for SLSR has been ongoing since 1st January 1995 and uses multiple overlapping
sources of notification, but more recently focussing on notification sources in hospitals, in
line with the evolution and reorganisation of the stroke care pathway. Since the
centralisation of London stroke services in 2010, all suspected stroke patients are taken by
ambulance to one of 8 hyper acute stroke units. These units provide 24/7 access to specialist
care and evidence based treatment to admitted patients. Notification sources for the new data
collection will include these hyper acute stroke units, stroke units, outpatient stroke
clinics, radiology and other relevant wards. Stroke patients presenting anywhere in the
health service including A&E departments or GP surgeries should be identifiable from these
sources.
The study will use 8 hospital centres: Primary sites at St Thomas' and King's College
Hospitals and secondary sites at St George's, Charing Cross, Royal London, Princess Royal
University, University College London, and Chelsea and Westminster hospitals. Primary sites
are hospitals within the boundaries of the study area. According to the current service
organisation they should receive all patients resident within the study area. King's College
Hospital has both a hyper acute stroke unit and a stroke unit, while St Thomas' has a stoke
unit only. Both sites have run 'Transient Ischaemic Attack (TIA) clinic', which is an
acute/urgent referral service largely from A+E and primary care for the assessment of people
with transient neurological symptoms or late presentation of stroke. These units and clinics
will serve as primary notification sources. Patients living near the boundaries of the study
area may be admitted to hospitals outside the district and the ambulance system may
occasionally take patients to outlying hospitals. These patients will normally be repatriated
to the stroke units at their local hospitals (the primary sites) and in many cases could be
notified from there. The inclusion of relevant hospitals as secondary sites will ensure
capture of the few cases who will be discharged home directly rather than repatriated.
Study teams will visit the hyper acute stroke unit at King's College Hospital and the stroke
units at both hospitals and review electronic patient records daily during the working week.
Outpatient stroke clinics take place twice weekly at both hospitals. Study teams will visit
the clinics and screen patient records to identify mild stroke patients (including those
formerly classed as TIAs) not captured at the hyper acute unit and stroke units. This will be
a key site for notification of lower risk events, which are not typically referred to stroke
units.
Teams will also screen MRI and CT requests and reports. This screening will be done daily at
King's College Hospital and weekly (based on current method) at St Thomas'.
Notification from secondary sites will be primarily via local research staff contacting the
field work team, due to the small numbers of eligible patients admitted to these hospitals.
Inclusion of scan positive mild strokes with short symptom duration (previously TIAs) is the
key adaptation to the fieldwork to capture the ICD-11 definition. These patients will
typically present to A&E or primary care. A&E departments in participating hospitals have a
low threshold for stroke unit and scan referrals and notification of these events is planned
to take place primarily via these mechanisms. Similarly, the smaller number of patients
presenting in primary care will usually be referred to the stroke clinic for assessment and
notification will take place there.
Patients admitted to other hospital wards should be captured via scan reports. Links with
wards that may deal with less typical stroke events, such as subarachnoid haemorrhage on
neurosurgical high dependency units, will be established as back up notification sources.
Subject selection will include some potential participants who have died a very short time
after admission to hospital and before it was possible to seek prospective consent. It is
critical that these people can form part of the study, and are not excluded, since they are
likely to be people who have had the most severe stroke, and are likely to disproportionately
comprise people who have experienced gaps in care, or other health inequalities which the
study aims to address.
SLSR recorded 286, 273 and 304 first time strokes in 2018, 2019 and 2020 respectively.
Inclusion of scan positive TIAs has been estimated to lead to an approximately 33% increase
in stroke incidence It is therefore anticipated that approximately 400 patients will be
invited per year. Historically only a very small percentage (<5%) of patients decline to take
part, so it is anticipated the majority of invited patients will be registered.
Patients will complete questionnaires covering details of the stroke, demographic details,
functional status, cognitive function, mental health and quality of life at defined intervals
during the study. These will be delivered as interviews with study staff lasting
approximately 40 minutes. Relevant clinical data will be extracted from clinical records from
standard stroke care. Participants will not undergo further clinical or radiological
assessments.
There are no clinical procedures or interventions as part of this study, but the participants
will be invited to take part in follow up interviews.
Patients will complete an initial interview then follow up interviews at 3 months and 1 year.
Newly recruited patients will be followed up annually from year 1-5 (within the lifetime of
this programme, follow up at 10 and 15 years may take place subject to further funding and
continuation of the SLSR) and currently enrolled participants will be further followed up at
5 years, 10 years and 15 years.Follow up assessments will always be offered as interviews
with a field worker, but may be delivered as self-completion postal questionnaires if
patients prefer.
Recurrent strokes occurring in enrolled participants will be detected using the same field
work methods described in section 8 for initial strokes. Participants will also be asked if
they had any further strokes at each follow up interview. An additional follow up interview
will be offered following each recurrence.
The South London Stroke Register is different from many fixed recruitment studies, in that it
aims to measure changes in stroke incidence, care, and outcome over time. To do this, we use
the gold standard methodology which requires identifying all people in an area with stroke,
and not with a fixed participant or time limit. The SLSR has been running continuously since
1995. We currently have funding in place until October 2026; but envisage that the SLSR will
continue beyond this.
This is an observational study with no interventions delivered. No serious adverse events are
likely to occur as a result of study procedures within this design.
It is anticipated that any distress or intrusion due to the study will be minimal as patient
involvement consists of short interviews (approximately 40 min), organised to suit the
patient's preferred time and mode (e.g. home visit, telephone interview or postal
questionnaire). Before each follow-up, verbal consent is sought to conduct the interview.
However, some patients may feel distressed when being asked questions related to their health
and lifestyle. Participants will be informed of their ability to stop or interrupt the
interview at any time. The interview will be stopped should there be any emotional distress
and commenced only when the patient is ready to go on. Stroke survivors from the King's
College London Stroke Research Patients and Family Group consulted in the course of this
study did not feel that the questions asked posed a significant burden to patients.
Patients have the right to permanently withdraw from any future follow-ups without any need
for justifications if they so wish, without giving a reason.
The overall stroke research programme, of which the SLSR is a part, is managed by a Programme
Executive Group (PEG), chaired jointly by the Chief Investigator and SLSR lead. The PEG meets
bi-weekly to review study progress, discuss outputs, necessary research staff training, etc.
The PEG is overseen by an independent NIHR Programme Steering Committee (PSC), which includes
a patient representative. The PEG and PSC will form together the Programme Board (PB), who
will discuss Programme governance. The PB will meet bi-annually with the Stakeholder
Engagement Group, (SEG) to report its governance decisions. The SEG as well as our Stroke
Research Patients and Family Group will be asked for peer review and feedback regarding the
study progress and interim findings. These arrangements are in accordance with the Funder's
monitoring and audit procedures.
Any protocol violations will be reported to the study sponsor. Serious breaches will be
reported by the sponsor to the REC within 7 days from becoming aware of the event.
